A little over a year ago, Medtronic brought in a complete outsider to reinvigorate a company whose biggest divisions were slowing down.
Omar Ishrak is known for having engineered a small miracle at GE when Jack Welch installed him to run the ultrasound division in the company. Ishrak transformed the business — a business that in Welch’s words had some “false starts” — into a billion-dollar operation thereby catapulting himself into the topmost ranks of the company. And the world, including Medtronic’s board of directors, noticed.
On July 11, an executive who follows Ishrak tweeted the following:
Why Pharma Companies Should Look To Social Media For Better Patient Insight
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.
Closing the Quality-Affordability Gap in Workplace Mental Health
In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable.
Today, Ishrak responded to Altraif’s tweet like this:
It might take a while to bring about such a major turnaround at the world’s largest medical device company. Yet, Ishrak can take heart in the fact that, at least from a vision perspective, Medtronic appears to be headed the right way.